XML 36 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Q3) - USD ($)
$ in Thousands
Total
Common Class I
Common Class 2
As Previously Reported
Adjustment
Common Stock
Common Class I
Common Stock
Common Class 2
Common Stock
As Previously Reported
Common Class I
Common Stock
As Previously Reported
Common Class 2
Common Stock
Adjustment
Common Class I
Common Stock
Adjustment
Common Class 2
Additional Paid-in Capital
Additional Paid-in Capital
As Previously Reported
Additional Paid-in Capital
Adjustment
Accumulated Deficit
Accumulated Deficit
As Previously Reported
Accumulated Deficit
Adjustment
Beginning balance at Dec. 31, 2017 $ 50,429     $ (81,949) $ 132,378             $ 139,143 $ 6,772 $ 132,371 $ (88,724) $ (88,724) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock-based compensation expense 1,796                     1,796     0    
Net loss (18,231)                     0     (18,231)    
Ending balance at Dec. 31, 2018 $ 34,120                     141,065     (106,955)    
Ending balance (in shares) at Dec. 31, 2019 0     68,383,000 (68,383,000)                        
Ending balance at Dec. 31, 2019 $ 0     $ 150,356 $ (150,356)                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock-based compensation expense 2,114                     2,114     0    
Net loss (22,803)                     0     (22,803)    
Ending balance (in shares) at Dec. 31, 2019           91,421,000 8,197,000 31,235,000 0 60,186,000 8,197,000            
Ending balance at Dec. 31, 2019 16,466     $ (133,894) $ 150,360 $ 9 $ 1 $ 3 $ 0 $ 6 $ 1 144,306 11,933 132,373 (127,850) (145,830) 17,980
Ending balance at Sep. 30, 2020 0                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock under stock plans (Shares)           460,000                      
Issuance of common stock under stock plans 300                     300          
Stock-based compensation expense 1,987                     1,987          
Net loss (12,714)                           (12,714)    
Ending balance (in shares) at Sep. 30, 2020           91,881,000 8,197,000                    
Ending balance at Sep. 30, 2020 $ 6,039         $ 9 $ 1         146,593     (140,564)    
Beginning balance (in shares) at Dec. 31, 2019 0     68,383,000 (68,383,000)                        
Beginning balance at Dec. 31, 2019 $ 0     $ 150,356 $ (150,356)                        
Ending balance (in shares) at Dec. 31, 2020 0     68,383,000 (68,383,000)                        
Ending balance at Dec. 31, 2020       $ 159,028 $ (159,028)                        
Beginning balance (in shares) at Dec. 31, 2019           91,421,000 8,197,000 31,235,000 0 60,186,000 8,197,000            
Beginning balance at Dec. 31, 2019 $ 16,466     (133,894) 150,360 $ 9 $ 1 $ 3 $ 0 $ 6 $ 1 144,306 11,933 132,373 (127,850) (145,830) 17,980
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock-based compensation expense 3,063                     3,063     0    
Net loss (17,027)                     0     (17,027)    
Ending balance (in shares) at Dec. 31, 2020   92,760,000 8,197,000     92,760,000   32,574,000   60,186,000 8,197,000            
Ending balance at Dec. 31, 2020 3,810     (155,223) 159,033 $ 9 $ 1 $ 3 0 $ 6 $ 1 148,677 16,301 132,376 (144,877) (171,527) 26,650
Ending balance at Sep. 30, 2020 0                                
Beginning balance (in shares) at Jun. 30, 2020           91,733,000 8,197,000                    
Beginning balance at Jun. 30, 2020 7,880         $ 9 $ 1         145,719     (137,849)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock under stock plans (in shares)           148,000                      
Issuance of common stock under stock plans 48                     48          
Stock-based compensation expense 826                     826          
Net loss (2,715)                           (2,715)    
Ending balance (in shares) at Sep. 30, 2020           91,881,000 8,197,000                    
Ending balance at Sep. 30, 2020 6,039         $ 9 $ 1         146,593     (140,564)    
Beginning balance at Dec. 31, 2020       159,028 (159,028)                        
Beginning balance (in shares) at Dec. 31, 2020   92,760,000 8,197,000     92,760,000   32,574,000   60,186,000 8,197,000            
Beginning balance at Dec. 31, 2020 $ 3,810     $ (155,223) $ 159,033 $ 9 1 $ 3 0 $ 6 $ 1 148,677 16,301 132,376 (144,877) (171,527) 26,650
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance and vesting of Earnout Shares (shares) 10,917,736                                
Beginning balance (in shares) at Dec. 31, 2020 0     68,383,000 (68,383,000)                        
Beginning balance at Dec. 31, 2020       $ 159,028 $ (159,028)                        
Ending balance (in shares) at Sep. 30, 2021 0                                
Ending balance at Sep. 30, 2021 $ 0                                
Beginning balance (in shares) at Dec. 31, 2020   92,760,000 8,197,000     92,760,000   32,574,000   60,186,000 8,197,000            
Beginning balance at Dec. 31, 2020 3,810     $ (155,223) $ 159,033 $ 9 $ 1 $ 3 $ 0 $ 6 $ 1 148,677 $ 16,301 $ 132,376 (144,877) $ (171,527) $ 26,650
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Shares issued for exercise of warrants (in shares)           2,000                      
Shares issued for exercise of warrants 26                     26          
Reverse recapitalization and PIPE Financing (Note 4) (shares)           44,522,000 (1,659,000)                    
Reverse recapitalization and PIPE Financing (Note 3) 329,622         $ 5           329,617          
Fair value of Earnout Shares (Note 3) (230,995)                     (230,995)          
Issuance and vesting of Earnout Shares (shares)           10,204,000 713,000                    
Issuance and vesting of Earnout Shares (Note 3) 237,009         $ 1           237,008          
Issuance of common stock under stock plans (Shares)           3,875,000                      
Issuance of common stock under stock plans 5,271                     5,271          
Stock-based compensation expense 20,446                     20,446          
Shares exchanged in connection with Secondary Offering (shares)           2,028,000 (2,028,000)                    
Net loss (44,724)                           (44,724)    
Ending balance (in shares) at Sep. 30, 2021   153,391,000 5,223,000     153,391,000 5,223,000                    
Ending balance at Sep. 30, 2021 $ 320,465         $ 15 $ 1         510,050     (189,601)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Reverse recapitalization and PIPE Financing (Note 4) (shares) 41,492,000                                
Shares exchanged in connection with Secondary Offering (shares) 20,000,000                                
Shares exchanged in connection with Secondary Offering (in shares) 20,000,000                                
Ending balance (in shares) at Jan. 12, 2021 145,266,000 138,728,373 6,537,735                            
Ending balance (in shares) at Sep. 30, 2021 0                                
Ending balance at Sep. 30, 2021 $ 0                                
Beginning balance (in shares) at Jun. 30, 2021           150,649,000 7,251,000                    
Beginning balance at Jun. 30, 2021 324,374         $ 15 $ 1         502,765     (178,407)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock under stock plans (in shares)           714,000                      
Issuance of common stock under stock plans 1,371                     1,371          
Stock-based compensation expense 5,914                     5,914          
Shares exchanged in connection with Secondary Offering (shares)           2,028,000 (2,028,000)                    
Net loss (11,194)                           (11,194)    
Ending balance (in shares) at Sep. 30, 2021   153,391,000 5,223,000     153,391,000 5,223,000                    
Ending balance at Sep. 30, 2021 $ 320,465         $ 15 $ 1         $ 510,050     $ (189,601)